Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : RXSD Rexall Sundown -- Ignore unavailable to you. Want to Upgrade?

To: Dorine Essey who wrote (109)	9/30/1998 6:36:00 PM
From: Anthony Wong	Respond to of 327

Dorine and all, in the Bloomberg article (which I don't think had been posted here), there's this NationsBanc analyst's comments: ''It's a good sign that the company wants to dispel rumors that it won't meet earnings estimates and has confidence in its own fundamentals,'' said Amy de Rham, an analyst at NationsBanc Montgomery Securities LLC, who rates the stock a ''buy.'' De Rham said that the company's not worried about pricing pressure from mass-market retailers, a concern that has prompted recent selling of vitamin makers. quote.bloomberg.com